Loading...
XNASYTEN
Market cap360kUSD
Dec 09, Last price  
0.35USD
Name

Yield10 Bioscience Inc

Chart & Performance

D1W1MN
XNAS:YTEN chart
P/E
—
P/S
6.02
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
100.00%
Rev. gr., 5y
-35.94%
Revenues
60k
-86.67%
3,678,2042,781,0014,590,0001,683,0001,555,0001,425,000448,0001,425,00042,316,0005,394,0002,800,0002,594,0001,159,000944,000556,000806,000799,000614,000450,00060,000
Net income
-14m
L+6.55%
-5,054,511-7,625,427-16,062,000-27,875,000-36,005,000-37,957,000-38,803,000-38,785,0003,630,000-30,506,000-29,534,000-23,681,000-7,604,000-9,396,000-9,185,000-12,956,000-10,206,000-11,031,000-13,566,000-14,455,000
CFO
-10m
L-11.72%
-980,667-4,394,184-3,603,000-10,900,000-18,392,000-25,759,000-31,995,000-31,731,000-31,736,000-26,648,000-24,244,000-21,863,000-14,700,000-8,202,000-8,754,000-8,654,000-8,659,000-9,253,000-11,404,000-10,068,000
Earnings
Mar 31, 2025

Profile

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
URL
https://www.yield10bio.com/
IPO date
Nov 10, 2006
Employees
30
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
60
-86.67%
450
-26.71%
614
-23.15%
Cost of revenue
14,767
14,557
12,884
Unusual Expense (Income)
NOPBT
(14,707)
(14,107)
(12,270)
NOPBT Margin
Operating Taxes
156
36
Tax Rate
NOPAT
(14,707)
(14,263)
(12,306)
Net income
(14,455)
6.55%
(13,566)
22.98%
(11,031)
8.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
103
(37)
15,746
BB yield
-5.42%
0.45%
-67.64%
Debt
Debt current
1,365
575
514
Long-term debt
5,271
4,725
5,812
Deferred revenue
Other long-term liabilities
(1,525)
7
Net debt
5,568
689
(9,928)
Cash flow
Cash from operating activities
(10,068)
(11,404)
(9,253)
CAPEX
(46)
(154)
(189)
Cash from investing activities
1,945
8,522
(4,578)
Cash from financing activities
6,871
(37)
15,746
FCF
(11,757)
(13,755)
(11,917)
Balance
Cash
1,068
4,347
15,990
Long term investments
264
264
Excess cash
1,065
4,588
16,223
Stockholders' equity
(414,297)
(399,877)
(386,257)
Invested Capital
414,389
406,927
405,453
ROIC
ROCE
EV
Common stock shares outstanding
331
205
197
Price
5.74
-85.67%
40.07
-66.07%
118.08
-14.88%
Market cap
1,902
-76.82%
8,205
-64.76%
23,281
69.72%
EV
7,470
8,894
13,353
EBITDA
(14,417)
(13,844)
(12,050)
EV/EBITDA
Interest
41
Interest/NOPBT